<h1>Growing demand for cardiac and diabetes drugs fuels franchise-based pharma expansion, driven by telemedicine, exclusivity, and low-investment models</h1> India's pharmaceutical market is expanding due to rising prevalence of cardiovascular and diabetic diseases, creating sustained demand for specialized drugs and growth in franchise-based distribution models, particularly in the cardiac and diabetic segment. Market drivers include rising disease burden, digital integration (telemedicine and e-prescriptions), lifestyle-related risk factors, regulatory tightening, and low-investment franchise opportunities. Franchise partners gain territorial exclusivity, product portfolios, marketing support, and reduced brand risk. Continued sector growth depends on product quality, regulatory compliance, and robust distribution networks, with experts noting franchise models can enhance healthcare access while offering entrepreneurial opportunities.